Adherence to treatment in patients with psoriasis

Journal of the European Academy of Dermatology and Venereology : JEADV
H L RichardsC E M Griffiths

Abstract

Non-adherence to medication is a chronic problem that impacts on healthcare professionals and patients alike. In psoriasis, a condition that presents patients with frequent and disabling physical, psychological and social effects, studies consistently suggest that up to 40% of patients do not use their medication as directed. Thus it is probable that poor adherence contaminates the clinical picture of response effectiveness in everyday practice. This educational paper reviews research that investigates adherence to medication in patients with psoriasis. It provides an overview of contributing factors and mediating variables. It is proposed that three specific facets appear to optimize patient adherence: an effective doctor-patient relationship; optimism with the treatment prescribed; and a limited 'nuisance' value of treatment in terms of side-effects and hassle of use. Various strategies to address adherence are suggested and it is argued that in order to enhance our understanding of adherence in patients with psoriasis, there needs to be an increasing focus on patients' beliefs about their condition and its management.

References

Jul 1, 1992·The British Journal of Dermatology·P M McHenry, V R Doherty
Jan 1, 1989·Journal of the American Academy of Dermatology·I H Ginsburg, B G Link
Sep 1, 1995·Patient Education and Counseling·E H Wagner
Feb 1, 1995·The British Journal of Dermatology·A Y Finlay, E C Coles
Feb 24, 1998·Family Practice·J Dowell, H Hudson
Aug 15, 1998·Journal of the American Academy of Dermatology·D G FortuneC E Griffiths
Dec 16, 1998·Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association·M R LearyS R Feldman
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
May 3, 2000·The British Journal of Dermatology·B KirbyC E Griffiths
May 16, 2000·The British Journal of Dermatology·M ScharlooH G Rooijmans
Jul 15, 2000·Dermatology : International Journal for Clinical and Investigative Dermatology·P C van de KerkhofM V Kuipers
Jul 15, 2000·Diabetes Care·W J Wishner, K E Lutfey
Mar 22, 2001·Journal of Psychosomatic Research·H L RichardsC J Main
May 22, 2001·The British Journal of Dermatology·C R TouwA Y Finlay
Jun 26, 2001·Journal of the American Academy of Dermatology·B KirbyC E Griffiths
Sep 22, 2001·BMJ : British Medical Journal·B S Bloom
Nov 13, 2001·The British Journal of Dermatology·C RenziM Braga
Apr 16, 2002·The British Journal of Dermatology·D G FortuneC E M Griffiths
Sep 28, 2002·BMJ : British Medical Journal·Peter Maguire, Carolyn Pitceathly
Oct 31, 2002·Journal of General Internal Medicine·Robert A BellRahman Azari
Mar 5, 2004·Patient Education and Counseling·Frode Gallefoss
Mar 5, 2004·Patient Education and Counseling·H Worth, Y Dhein
Apr 21, 2004·Archives of Dermatology·Sameh Said Zaghloul, Mark Jeremy David Goodfield
Jun 12, 2004·The Journal of Investigative Dermatology·Helen L RichardsChristopher E M Griffiths
Dec 21, 2004·The British Journal of Dermatology·D G FortuneC E M Griffiths
Jan 1, 1997·International Quarterly of Community Health Education·O O OkunribidoA A Adeyemo

❮ Previous
Next ❯

Citations

Jul 26, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J Schmitt, M Meurer
Feb 22, 2012·Archives of Dermatological Research·A NastUNKNOWN Berufsverband Deutscher Dermatologen
Jul 7, 2009·International Journal of Behavioral Medicine·Dean G CruessStephen E Kimmel
Feb 7, 2012·Annales de dermatologie et de vénéréologie·B Halioua
Jun 17, 2008·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·Michael E MurphyJohn A Zitelli
May 28, 2011·Pediatric Dermatology·Rachel M EllisJudith V Williams
Feb 5, 2011·Dermatology : International Journal for Clinical and Investigative Dermatology·Richard G B LangleyDušica Curčić
Oct 22, 2013·BMC Family Practice·Pauline A NelsonUNKNOWN IMPACT Team
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Marina PapoutsakiSergio Chimenti
Jan 22, 2014·PharmacoEconomics·Aleksandra TorbicaFabio Ayala
Nov 28, 2014·The Journal of Dermatological Treatment·Bruno HaliouaJean-François Stalder
Oct 27, 2006·Expert Opinion on Emerging Drugs·Gino A Vena, Nicoletta Cassano
May 8, 2010·Expert Opinion on Biological Therapy·Elizabeth E Uhlenhake, Steven R Feldman
Nov 9, 2010·The British Journal of Dermatology·M CourtenayJ Peters
May 15, 2013·Actas dermo-sifiliográficas·S RosJ M Carrascosa
Jun 12, 2012·Journal of the American Academy of Dermatology·Sabrina L MartinSteven R Feldman
Feb 7, 2012·Annales de dermatologie et de vénéréologie·B Halioua
Jan 31, 2012·Dermatologic Clinics·O D van CranenburghJ de Korte
Oct 22, 2011·Journal of the American Academy of Dermatology·Astrid SchmiederWiebke K Peitsch
Jan 20, 2010·Clinics in Dermatology·Carlos FerrándizAram Boada
Aug 30, 2008·Clinics in Dermatology·Lars Alexander SchneiderKarin Scharffetter-Kochanek
Oct 7, 2008·Journal of the American Academy of Dermatology·Steven R FeldmanUNKNOWN International Psoriasis Council
Sep 27, 2008·Journal of the American Academy of Dermatology·Andreas StormJørgen Serup
May 10, 2008·Journal of the American Academy of Dermatology·Andreas StormJørgen Serup
Jul 31, 2007·Lancet·Alan Menter, Christopher Em Griffiths
Feb 14, 2008·Journal of the European Academy of Dermatology and Venereology : JEADV·G GokdemirA Köşlü
Apr 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·A Bewley, B Page
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·S DevauxC Paul
May 26, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·C PaulJ-P Ortonne
Mar 23, 2012·International Journal of Dermatology·Dario Nicolas KivelevitchEduardo Adolfo Rodríguez
Apr 10, 2013·The British Journal of Dermatology·O D van CranenburghE M A Smets
Aug 5, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·E AltobelliK Peris
Apr 12, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Oct 29, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·K PappV P Rives
Aug 14, 2012·The British Journal of Dermatology·P A NelsonUNKNOWN IMPACT Team
Mar 26, 2011·Annals of the New York Academy of Sciences·Newman YeildingCynthia Guzzo
Apr 2, 2014·Journal of the European Academy of Dermatology and Venereology : JEADV·I ZschockeK Reich
Nov 6, 2015·Journal of the European Academy of Dermatology and Venereology : JEADV·L EissingM Augustin
May 28, 2014·The British Journal of Dermatology·C E M GriffithsL Mallbris
Jul 30, 2011·The Journal of Dermatological Treatment·Sue Ann ChanAnthony D Ormerod

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Dermatology
Sameh Said Zaghloul, Mark Jeremy David Goodfield
Journal of the European Academy of Dermatology and Venereology : JEADV
S FouéréH Pawin
Journal of the European Academy of Dermatology and Venereology : JEADV
G GokdemirA Köşlü
Journal of the American Academy of Dermatology
S R FeldmanInternational Psoriasis Council
© 2022 Meta ULC. All rights reserved